Harel Dahari

Summary

Affiliation: University of Illinois at Chicago
Country: USA

Publications

  1. pmc Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    Antivir Ther 14:459-64. 2009
  2. pmc Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    J Hepatol 53:460-7. 2010
  3. pmc A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Gastroenterology 136:1402-9. 2009
  4. pmc Modeling complex decay profiles of hepatitis B virus during antiviral therapy
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    Hepatology 49:32-8. 2009
  5. pmc Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Gastroenterology 139:965-74. 2010
  6. pmc Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    J Virol 83:6383-90. 2009

Detail Information

Publications6

  1. pmc Modelling hepatitis C virus kinetics: the relationship between the infected cell loss rate and the final slope of viral decay
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    Antivir Ther 14:459-64. 2009
    ..In standard models, lambda is approximately epsilondelta when the viral clearance rate c>>delta, as has been previously estimated...
  2. pmc Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
    J Hepatol 53:460-7. 2010
    ..We sought to estimate the pharmacokinetics and pharmacodynamics of PEG-IFN and determine whether these parameters predict treatment outcome...
  3. pmc A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Gastroenterology 136:1402-9. 2009
    ....
  4. pmc Modeling complex decay profiles of hepatitis B virus during antiviral therapy
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
    Hepatology 49:32-8. 2009
    ..Conclusion: We show via kinetic modeling how a variety of HBV DNA decay profiles can arise in treated patients...
  5. pmc Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA
    Gastroenterology 139:965-74. 2010
    ..To draw meaningful conclusions about the efficacy of HCV vaccines in chimpanzees, we performed statistical analyses of data from previously published studies from different groups...
  6. pmc Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon
    Harel Dahari
    Department of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA
    J Virol 83:6383-90. 2009
    ..As such, dissection of HCV IFN-alpha inhibition kinetics in vitro has brought us closer to understanding the mechanism(s) by which IFN-alpha may be inhibiting HCV in vivo...